Under construction – not a live service
Sign in
Taking people in MexicoNo phase

A Questionnaire Measuring Adherence to Breathing Rehabilitation in Lung Cancer Patients

Tests a new questionnaire on how well lung cancer patients keep up with breathing rehabilitation.

Plain-language title generated from the registry record
Registry title: Scale of Therapeutic Adherence to Respiratory Rahabilitation for Lung Cancer

Key facts

Where
Mexico City, MexicoSee the site

Where in Mexico

  • Instituto Nacional de CancerologiaMexico City, MexicoTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Instituto Nacional de Cancerologia de Mexico
Trial code
NCT06477302
Record updated
23 December 2025
Original description
The goal of this non experimental, transversal instrument study is to Construct and determine the reliability and validity of the Scale of Therapeutic Adherence for Respiratory Rehabilitation in Lung Cancer in Mexican patients with a lung cancer diagnosis.Read full original descriptionShow less

Construction and Psychometric Properties of the Therapeutic Adherence Scale for Respiratory Rehabilitation in Lung Cancer (STA-RR-LC).

The goal of this non experimental, transversal instrument study is to Construct and determine the reliability and validity of the Scale of Therapeutic Adherence for Respiratory Rehabilitation in Lung Cancer in Mexican patients with a lung cancer diagnosis.

The main question it aims to answer is: What is the reliability and validity of the Scale of Therapeutic Adherence for Respiratory Rehabilitation in Lung Cancer of the patients with this diagnosis that are currently undergoing an assessment or follow up program of Respiratory Rehabilitation?

The Scale of Therapeutic Adherence for Respiratory Rehabilitation in Lung Cancer (STA-RR-LC) will be psychometrically valid and reliable for the evaluation of therapeutic adherence on patients with lung cancer that are undergoing an assessment or follow up of Respiratory Rehabilitation.Participants will be asked to fill out an Identification card and fill out the fifty-six items presented on the STA-RR-LC.

Inclusion: Patients diagnosed with lung cancer (SCLC and NSCLC); Over 18 years of age; Voluntary participation by understanding and accepting the informed consent letter; Patients undergoing Respiratory Rehabilitation treatment with one month assessment and follow-up; Patients in active medical treatment; Any clinical stage; Karnofsky Index ≥ 70.

Exclusion: Severe psychiatric conditions (schizophrenia or psychotic disorders) and/or addiction to any psychoactive substance (this will be identified as reported in the INCanet file); Severe hearing or visual problems that prevent them from understanding the instructions and answering the instruments (this will be identified as reported in the clinical record file); Attentional or memory problems that prevent them from understanding the instructions and answering the instruments (this will be identified as reported in the INCanet file).

ClinicalTrials.gov NCT06477302